Skip to main content
SpringerLink
Log in
SpringerLink
Log in

PET/MR in Colorectal Cancer

  • Chapter
  • First Online:
PET/MRI

Abstract

Colorectal cancer (CRC) is the third most common malignant neoplasm in mankind with slightly less than 1.2 million new cases and more than 600,000 deaths worldwide in 2008 [1, 2]. Colorectal cancer is frequently associated with metastatic disease – either synchronous or metachronous – with the highest number of metastases to the lymph nodes and liver. In CRC patients’ early detection of metastases has a strong impact on prognosis since effective interventional as weäll as surgical treatment options can be offered leading to relatively high survival rates [3]. If disease course is followed closely with imaging, survival can be significantly improved [4].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010;46(4):765–81.

    Article  PubMed  CAS  Google Scholar 

  2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–917.

    Article  PubMed  CAS  Google Scholar 

  3. Kemeny NE, Gonen M. Hepatic arterial infusion after liver resection. N Engl J Med. 2005;352(7):734–5.

    Article  PubMed  CAS  Google Scholar 

  4. Figueredo A, Rumble RB, Maroun J, Earle CC, Cummings B, McLeod R, Zuraw L, Zwaal C, Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario’s Program in Evidence-based Care. Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer. 2003;3:26.

    Article  PubMed  Google Scholar 

  5. Grassetto G, Marzola MC, Minicozzi A, Al-Nahhas A, Rubello D. F-18 FDG PET/CT in rectal carcinoma: where are we now? Clin Nucl Med. 2011;36(10):884–8.

    Article  PubMed  Google Scholar 

  6. Sanli Y, Kuyumcu S, Ozkan ZG, Kilic L, Balik E, Turkmen C, Has D, Isik G, Asoglu O, Kapran Y, Adalet I. The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels. Ann Nucl Med. 2012;26(7):551–8.

    Article  PubMed  Google Scholar 

  7. Selzner M, Hany TF, Wildbrett P, McCormack L, Kadry Z, Clavien PA. Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg. 2004;240(6):1027–34.

    Article  PubMed  Google Scholar 

  8. Davey K, Heriot AG, Mackay J, Drummond E, Hogg A, Ngan S, Milner AD, Hicks RJ. The impact of 18-fluorodeoxyglucose positron emission tomography-computed tomography on the staging and management of primary rectal cancer. Dis Colon Rectum. 2008;51(7):997–1003.

    Article  PubMed  CAS  Google Scholar 

  9. Gearhart SL, Frassica D, Rosen R, Choti M, Schulick R, Wahl R. Improved staging with pretreatment positron emission tomography/computed tomography in low rectal cancer. Ann Surg Oncol. 2006;13(3):397–404.

    Article  PubMed  Google Scholar 

  10. Wiering B, Krabbe PF, Jager GJ, Oyen WJ, Ruers TJ. The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases. Cancer. 2005;104(12):2658–70.

    Article  PubMed  Google Scholar 

  11. Schmidt GP, Baur-Melnyk A, Haug A, Utzschneider S, Becker CR, Tiling R, Reiser MF, Hermann KA. Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer. Eur Radiol. 2009;19(6):1366–78.

    Article  PubMed  CAS  Google Scholar 

  12. Ichikawa T, Erturk SM, Motosugi U, Sou H, Iino H, Araki T, Fujii H. High-B-value diffusion-weighted MRI in colorectal cancer. AJR Am J Roentgenol. 2006;187(1):181–4.

    Article  PubMed  Google Scholar 

  13. Morita N, Harada M, Otsuka H, Melhem ER, Nishitani H. Clinical application of MR spectroscopy and imaging of brain tumor. Magn Reson Med Sci. 2010;9(4):167–75.

    Article  PubMed  CAS  Google Scholar 

  14. Zhong JH, Gore JC. Studies of restricted diffusion in heterogeneous media containing variations in susceptibility. Magn Reson Med. 1991;19(2):276–84.

    Article  PubMed  CAS  Google Scholar 

  15. Heusch P, Buchbender C, Beiderwellen K, Nensa F, Hartung-Knemeyer V, Lauenstein TC, Bockisch A, Forsting M, Antoch G, Heusner TA. Standardized uptake values for [18F] FDG in normal organ tissues: comparison of whole-body PET/CT and PET/MRI. Eur J Radiol. 2013;82(5):870–6.

    Article  PubMed  Google Scholar 

  16. Kalemis A, Delattre BM, Heinzer S. Sequential whole-body PET/MR scanner: concept, clinical use, and optimisation after two years in the clinic. The manufacturer’s perspective. MAGMA. 2013;26(1):5–23.

    Article  PubMed  CAS  Google Scholar 

  17. Schwenzer NF, Schmidt H, Claussen CD. Whole-body MR/PET: applications in abdominal imaging. Abdom Imaging. 2012;37(1):20–8.

    Article  PubMed  CAS  Google Scholar 

  18. Drzezga A, Souvatzoglou M, Eiber M, Beer AJ, Fürst S, Martinez-Möller A, Nekolla SG, Ziegler S, Ganter C, Rummeny EJ, Schwaiger M. First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses. J Nucl Med. 2012;53(6):845–55.

    Article  PubMed  Google Scholar 

  19. Coombs BD, Szumowski J, Coshow W. Two-point Dixon technique for water-fat signal decomposition with B0 inhomogeneity correction. Magn Reson Med. 1997;38(6):884–9.

    Article  PubMed  CAS  Google Scholar 

  20. Martinez-Möller A, Souvatzoglou M, Delso G, Bundschuh RA, Chefd’hotel C, Ziegler SI, Navab N, Schwaiger M, Nekolla SG. Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data. J Nucl Med. 2009;50(4):520–6.

    Article  PubMed  Google Scholar 

  21. Stolzmann P, Veit-Haibach P, Chuck N, Rossi C, Frauenfelder T, Alkadhi H, von Schulthess G, Boss A. Detection rate, location, and size of pulmonary nodules in trimodality PET/CT-MR: comparison of low-dose CT and Dixon-based MR imaging. Invest Radiol. 2013;48(5):241–6.

    Article  PubMed  Google Scholar 

  22. Wagenknecht G, Kaiser HJ, Mottaghy FM, Herzog H. MRI for attenuation correction in PET: methods and challenges. MAGMA. 2013;26(1):99–113.

    Article  PubMed  Google Scholar 

  23. Keereman V, Fierens Y, Broux T, De Deene Y, Lonneux M, Vandenberghe S. MRI-based attenuation correction for PET/MRI using ultrashort echo time sequences. J Nucl Med. 2010;51(5):812–18.

    Article  PubMed  Google Scholar 

  24. Keereman V, Holen RV, Mollet P, Vandenberghe S. The effect of errors in segmented attenuation maps on PET quantification. Med Phys. 2011;38(11):6010–19.

    Article  PubMed  Google Scholar 

  25. Berker Y, Franke J, Salomon A, Palmowski M, Donker HC, Temur Y, Mottaghy FM, Kuhl C, Izquierdo-Garcia D, Fayad ZA, Kiessling F, Schulz V. MRI-based attenuation correction for hybrid PET/MRI systems: a 4-class tissue segmentation technique using a combined ultrashort-echo-time/Dixon MRI sequence. J Nucl Med. 2012;53(5):796–804.

    Article  PubMed  Google Scholar 

  26. Kershah S, Partovi S, Traughber BJ, Muzic RF Jr., Schluchter MD, O’Donnell JK, Faulhaber P. Comparison of standardized uptake calues in normal structures between PET/CT and PET/MRI in an oncology patient population. Mol Imaging Biol. 2013; 15(6):776–85.

    Article  PubMed  Google Scholar 

  27. Partovi S, Kohan A, Gaeta C, Rubbert C, Vercher-Conejero JL, Jones RS, O’Donnell JK, Wojtylak P, Faulhaber P. Image quality assessment of automatic three-segment MR attenuation correction vs. CT attenuation correction. Am J Nucl Med Mol Imaging. 2013;3(3):291–9.

    PubMed  Google Scholar 

  28. Buchbender C, Heusner TA, Lauenstein TC, Bockisch A, Antoch G. Oncologic PET/MRI, part 1: tumors of the brain, head and neck, chest, abdomen, and pelvis. J Nucl Med. 2012;53(6):928–38.

    Article  PubMed  Google Scholar 

  29. Martinez-Möller A, Eiber M, Nekolla SG, Souvatzoglou M, Drzezga A, Ziegler S, Rummeny EJ, Schwaiger M, Beer AJ. Workflow and scan protocol considerations for integrated whole-body PET/MRI in oncology. J Nucl Med. 2012;53(9):1415–26.

    Article  PubMed  Google Scholar 

  30. Sani F, Foresti M, Parmiggiani A, D’Andrea V, Manenti A, Amorotti C, Scotti R, Gallo E, Torricelli P. 3-T MRI with phased-array surface coil in the local staging of rectal cancer. Radiol Med. 2011;116(3):375–88.

    Article  PubMed  CAS  Google Scholar 

  31. Lauenstein TC, Saar B, Martin DR. MR colonography: 1.5T versus 3T. Magn Reson Imaging Clin N Am. 2007;15(3):395–402.

    Article  PubMed  Google Scholar 

  32. Dagia C, Ditchfield M, Kean M, Catto-Smith A. Feasibility of 3-T MRI for the evaluation of Crohn disease in children. Pediatr Radiol. 2010;40(10):1615–24.

    Article  PubMed  Google Scholar 

  33. Boll DT, Merkle EM. Imaging at higher magnetic fields: 3 T versus 1.5 T. Magn Reson Imaging Clin N Am. 2010;18(3):549–64.

    Article  PubMed  Google Scholar 

  34. Hartmann D, Bassler B, Schilling D, Adamek HE, Jakobs R, Pfeifer B, Eickhoff A, Zindel C, Riemann JF, Layer G. Colorectal polyps: detection with dark-lumen MR colonography versus conventional colonoscopy. Radiology. 2006;238(1):143–9.

    Article  PubMed  Google Scholar 

  35. Saar B, Gschossmann JM, Bonel HM, Kickuth R, Vock P, Netzer P. Evaluation of magnetic resonance colonography at 3.0 T regarding diagnostic accuracy and image quality. Invest Radiol. 2008;43(8):580–6.

    Article  PubMed  Google Scholar 

  36. Fütterer JJ, Yakar D, Strijk SP, Barentsz JO. Preoperative 3T MR imaging of rectal cancer: local staging accuracy using a two-dimensional and three-dimensional T2-weighted turbo spin echo sequence. Eur J Radiol. 2008;65(1):66–71.

    Article  PubMed  Google Scholar 

  37. Kim HJ, Park SH, Pickhardt PJ, Yoon SN, Lee SS, Yee J, Kim DH, Kim AY, Kim JC, Yu CS, Ha HK. CT colonography for combined colonic and extracolonic surveillance after curative resection of colorectal cancer. Radiology. 2010;257(3):697–704.

    Article  PubMed  Google Scholar 

  38. Winawer SJ, Zauber AG, Fletcher RH, Stillman JS, O’Brien MJ, Levin B, Smith RA, Lieberman DA, Burt RW, Levin TR, Bond JH, Brooks D, Byers T, Hyman N, Kirk L, Thorson A, Simmang C, Johnson D, Rex DK, US Multi-Society Task Force on Colorectal Cancer; American Cancer Society. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology. 2006;130(6):1872–85.

    Article  PubMed  Google Scholar 

  39. Bond JH. Colon polyps and cancer. Endoscopy. 2003;35(1):27–35.

    Article  PubMed  CAS  Google Scholar 

  40. Herrmann KA, Paspulati RM, Lauenstein T, Reiser MF. Benefits and challenges in bowel MR imaging at 3.0 T. Top Magn Reson Imaging. 2010;21(3):165–75.

    Article  PubMed  Google Scholar 

  41. Ajaj W, Pelster G, Treichel U, Vogt FM, Debatin JF, Ruehm SG, Lauenstein TC. Dark lumen magnetic resonance colonography: comparison with conventional colonoscopy for the detection of colorectal pathology. Gut. 2003;52(12):1738–43.

    Article  PubMed  CAS  Google Scholar 

  42. Wessling J, Fischbach R, Borchert A, Kugel H, Allkemper T, Osada N, Heindel W. Detection of colorectal polyps: comparison of multi-detector row CT and MR colonography in a colon phantom. Radiology. 2006;241(1):125–31.

    Article  PubMed  Google Scholar 

  43. Graser A, Melzer A, Lindner E, Nagel D, Herrmann K, Stieber P, Schirra J, Mansmann U, Reiser MF, Göke B, Kolligs FT. Magnetic resonance colonography for the detection of colorectal neoplasia in asymptomatic adults. Gastroenterology. 2013;144(4):743–50.

    Article  PubMed  Google Scholar 

  44. Yasuda S, Fujii H, Nakahara T, Nishiumi N, Takahashi W, Ide M, Shohtsu A. 18F-FDG PET detection of colonic adenomas. J Nucl Med. 2001;42(7):989–92.

    PubMed  CAS  Google Scholar 

  45. van Kouwen MC, Nagengast FM, Jansen JB, Oyen WJ, Drenth JP. 2-(18F)-fluoro-2-deoxy-D-glucose positron emission tomography detects clinical relevant adenomas of the colon: a prospective study. J Clin Oncol. 2005;23(16):3713–17.

    Article  PubMed  Google Scholar 

  46. Berger KL, Nicholson SA, Dehdashti F, Siegel BA. FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features. AJR Am J Roentgenol. 2000;174(4):1005–8.

    Article  PubMed  CAS  Google Scholar 

  47. Vikram R, Iyer RB. PET/CT imaging in the diagnosis, staging, and follow-up of colorectal cancer. Cancer Imaging. 2008;8(Spec No A):S46–51.

    Article  PubMed  Google Scholar 

  48. Eiber M, Martinez-Möller A, Souvatzoglou M, Holzapfel K, Pickhard A, Löffelbein D, Santi I, Rummeny EJ, Ziegler S, Schwaiger M, Nekolla SG, Beer AJ. Value of a Dixon-based MR/PET attenuation correction sequence for the localization and evaluation of PET-positive lesions. Eur J Nucl Med Mol Imaging. 2011;38(9):1691–701.

    Article  PubMed  Google Scholar 

  49. Lambregts DM, Beets GL, Maas M, Curvo-Semedo L, Kessels AG, Thywissen T, Beets-Tan RG. Tumour ADC measurements in rectal cancer: effect of ROI methods on ADC values and interobserver variability. Eur Radiol. 2011;21(12):2567–74.

    Article  PubMed  Google Scholar 

  50. Beets-Tan RG, Beets GL, Vliegen RF, Kessels AG, Van Boven H, De Bruine A, von Meyenfeldt MF, Baeten CG, van Engelshoven JM. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet. 2001;357(9255):497–504.

    Article  PubMed  CAS  Google Scholar 

  51. Bipat S, Glas AS, Slors FJ, Zwinderman AH, Bossuyt PM, Stoker J. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging–a meta-analysis. Radiology. 2004;232(3):773–83.

    Article  PubMed  Google Scholar 

  52. Rao SX, Zeng MS, Chen CZ, Li RC, Zhang SJ, Xu JM, Hou YY. The value of diffusion-weighted imaging in combination with T2-weighted imaging for rectal cancer detection. Eur J Radiol. 2008;65(2):299–303.

    Article  PubMed  Google Scholar 

  53. Muhi A, Ichikawa T, Motosugi U, Sou H, Sano K, Araki T. Diffusion- and T2-weighted MR imaging of the liver: effect of intravenous administration of gadoxetic acid disodium. Magn Reson Med Sci. 2012;11(3):185–91.

    Article  PubMed  Google Scholar 

  54. Curvo-Semedo L, Lambregts DM, Maas M, Beets GL, Caseiro-Alves F, Beets-Tan RG. Diffusion-weighted MRI in rectal cancer: apparent diffusion coefficient as a potential noninvasive marker of tumor aggressiveness. J Magn Reson Imaging. 2012;35(6):1365–71.

    Article  PubMed  Google Scholar 

  55. Lambregts DM, Vandecaveye V, Barbaro B, Bakers FC, Lambrecht M, Maas M, Haustermans K, Valentini V, Beets GL, Beets-Tan RG. Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study. Ann Surg Oncol. 2011;18(8):2224–31.

    Article  PubMed  Google Scholar 

  56. Lambregts DM, Cappendijk VC, Maas M, Beets GL, Beets-Tan RG. Value of MRI and diffusion-weighted MRI for the diagnosis of locally recurrent rectal cancer. Eur Radiol. 2011;21(6):1250–8.

    Article  PubMed  Google Scholar 

  57. Dzik-Jurasz A, Domenig C, George M, Wolber J, Padhani A, Brown G, Doran S. Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet. 2002;360(9329):307–8.

    Article  PubMed  Google Scholar 

  58. Sun YS, Zhang XP, Tang L, Ji JF, Gu J, Cai Y, Zhang XY. Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging. Radiology. 2010;254(1):170–8.

    Article  PubMed  Google Scholar 

  59. Curvo-Semedo L, Lambregts DM, Maas M, Thywissen T, Mehsen RT, Lammering G, Beets GL, Caseiro-Alves F, Beets-Tan RG. Rectal cancer: assessment of complete response to preoperative combined radiation therapy with chemotherapy–conventional MR volumetry versus diffusion-weighted MR imaging. Radiology. 2011;260(3):734–43.

    Article  PubMed  Google Scholar 

  60. Koh DM, Chau I, Tait D, Wotherspoon A, Cunningham D, Brown G. Evaluating mesorectal lymph nodes in rectal cancer before and after neoadjuvant chemoradiation using thin-section T2-weighted magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 2008;71(2):456–61.

    Article  PubMed  Google Scholar 

  61. Koh DM, George C, Temple L, Collins DJ, Toomey P, Raja A, Bett N, Farhat S, Husband JE, Brown G. Diagnostic accuracy of nodal enhancement pattern of rectal cancer at MRI enhanced with ultrasmall superparamagnetic iron oxide: findings in pathologically matched mesorectal lymph nodes. AJR Am J Roentgenol. 2010;194(6):W505–13.

    Article  PubMed  Google Scholar 

  62. Lahaye MJ, Engelen SM, Kessels AG, de Bruïne AP, von Meyenfeldt MF, van Engelshoven JM, van de Velde CJ, Beets GL, Beets-Tan RG. USPIO-enhanced MR imaging for nodal staging in patients with primary rectal cancer: predictive criteria. Radiology. 2008;246(3):804–11.

    Article  PubMed  Google Scholar 

  63. Brown G, Radcliffe AG, Newcombe RG, Dallimore NS, Bourne MW, Williams GT. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg. 2003;90(3):355–64.

    Article  PubMed  CAS  Google Scholar 

  64. Yasui O, Sato M, Kamada A. Diffusion-weighted imaging in the detection of lymph node metastasis in colorectal cancer. Tohoku J Exp Med. 2009;218(3):177–83.

    Article  PubMed  CAS  Google Scholar 

  65. Kim DJ, Kim JH, Ryu YH, Jeon TJ, Yu JS, Chung J. Nodal staging of rectal cancer: high-resolution pelvic MRI versus 18F-FDGPET/CT. J Comput Assist Tomogr. 2011;35(5):531–4.

    Article  PubMed  Google Scholar 

  66. Osman MM, Cohade C, Nakamoto Y, Marshall LT, Leal JP, Wahl RL. Clinically significant inaccurate localization of lesions with PET/CT: frequency in 300 patients. J Nucl Med. 2003;44(2):240–3.

    PubMed  Google Scholar 

  67. Mawlawi O, Podoloff DA, Kohlmyer S, Williams JJ, Stearns CW, Culp RF, Macapinlac H, National Electrical Manufacturers Association. Performance characteristics of a newly developed PET/CT scanner using NEMA standards in 2D and 3D modes. J Nucl Med. 2004;45(10):1734–42.

    PubMed  Google Scholar 

  68. Stoeckli SJ, Steinert H, Pfaltz M, Schmid S. Is there a role for positron emission tomography with 18F-fluorodeoxyglucose in the initial staging of nodal negative oral and oropharyngeal squamous cell carcinoma. Head Neck. 2002;24(4):345–9.

    Article  PubMed  Google Scholar 

  69. Kong G, Jackson C, Koh DM, Lewington V, Sharma B, Brown G, Cunningham D, Cook GJ. The use of 18F-FDG PET/CT in colorectal liver metastases–comparison with CT and liver MRI. Eur J Nucl Med Mol Imaging. 2008;35(7):1323–9.

    Article  PubMed  CAS  Google Scholar 

  70. Sahani DV, Kalva SP, Fischman AJ, Kadavigere R, Blake M, Hahn PF, Saini S. Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET. AJR Am J Roentgenol. 2005;185(1):239–46.

    Article  PubMed  Google Scholar 

  71. Regge D, Campanella D, Anselmetti GC, Cirillo S, Gallo TM, Muratore A, Capussotti L, Galatola G, Floriani I, Aglietta M. Diagnostic accuracy of portal-phase CT and MRI with mangafodipir trisodium in detecting liver metastases from colorectal carcinoma. Clin Radiol. 2006;61(4):338–47.

    Article  PubMed  CAS  Google Scholar 

  72. Bartolozzi C, Donati F, Cioni D, Procacci C, Morana G, Chiesa A, Grazioli L, Cittadini G, Cittadini G, Giovagnoni A, Gandini G, Maass J, Lencioni R. Detection of colorectal liver metastases: a prospective multicenter trial comparing unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT. Eur Radiol. 2004;14(1):14–20.

    Article  PubMed  Google Scholar 

  73. Niekel MC, Bipat S, Stoker J. Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. Radiology. 2010;257(3):674–84.

    Article  PubMed  Google Scholar 

  74. Antoch G, Bockisch A. Combined PET/MRI: a new dimension in whole-body oncology imaging? Eur J Nucl Med Mol Imaging. 2009;36 Suppl 1:S113–20.

    Article  PubMed  Google Scholar 

  75. Eustace SJ, Walker R, Blake M, Yucel EK. Whole-body MR imaging. Practical issues, clinical applications, and future directions. Magn Reson Imaging Clin N Am. 1999;7(2):209–36.

    PubMed  CAS  Google Scholar 

  76. Schmidt GP, Schoenberg SO, Schmid R, Stahl R, Tiling R, Becker CR, Reiser MF, Baur-Melnyk A. Screening for bone metastases: whole-body MRI using a 32-channel system versus dual-modality PET-CT. Eur Radiol. 2007;17(4):939–49.

    Article  PubMed  Google Scholar 

  77. Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R, German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351(17):1731–40.

    Article  PubMed  CAS  Google Scholar 

  78. Park MJ, Kim SH, Lee SJ, Jang KM, Rhim H. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging for predicting tumor clearance of the mesorectal fascia after neoadjuvant chemotherapy and radiation therapy. Radiology. 2011;260(3):771–80.

    Article  PubMed  Google Scholar 

  79. Ito K, Kato T, Tadokoro M, Ishiguchi T, Oshima M, Ishigaki T, Sakuma S. Recurrent rectal cancer and scar: differentiation with PET and MR imaging. Radiology. 1992;182(2):549–52.

    PubMed  CAS  Google Scholar 

  80. Guillem JG, Moore HG, Akhurst T, Klimstra DS, Ruo L, Mazumdar M, Minsky BD, Saltz L, Wong WD, Larson S. Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer. J Am Coll Surg. 2004;199(1):1–7.

    Article  PubMed  Google Scholar 

  81. Smith MD, McCall JL. Systematic review of tumour number and outcome after radical treatment of colorectal liver metastases. Br J Surg. 2009;96(10):1101–13.

    Article  PubMed  CAS  Google Scholar 

  82. Flanagan FL, Dehdashti F, Ogunbiyi OA, Kodner IJ, Siegel BA. Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer. Ann Surg. 1998;227(3):319–23.

    Article  PubMed  CAS  Google Scholar 

  83. Flamen P, Hoekstra OS, Homans F, Van Cutsem E, Maes A, Stroobants S, Peeters M, Penninckx F, Filez L, Bleichrodt RP, Mortelmans L. Unexplained rising carcinoembryonic antigen (CEA) in the postoperative surveillance of colorectal cancer: the utility of positron emission tomography (PET). Eur J Cancer. 2001;37(7):862–9.

    Article  PubMed  CAS  Google Scholar 

  84. Vliegen RF, Beets GL, Lammering G, Dresen RC, Rutten HJ, Kessels AG, Oei TK, de Bruïne AP, van Engelshoven JM, Beets-Tan RG. Mesorectal fascia invasion after neoadjuvant chemotherapy and radiation therapy for locally advanced rectal cancer: accuracy of MR imaging for prediction. Radiology. 2008;246(2):454–62.

    Article  PubMed  Google Scholar 

  85. Hosonuma T, Tozaki M, Ichiba N, Sakuma T, Hayashi D, Yanaga K, Fukuda K. Clinical usefulness of diffusion-weighted imaging using low and high b-values to detect rectal cancer. Magn Reson Med Sci. 2006;5(4):173–7.

    Article  PubMed  Google Scholar 

  86. Song I, Kim SH, Lee SJ, Choi JY, Kim MJ, Rhim H. Value of diffusion-weighted imaging in the detection of viable tumour after neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer: comparison with T2 weighted and PET/CT imaging. Br J Radiol. 2012;85(1013):577–86.

    Article  PubMed  CAS  Google Scholar 

  87. Kim SH, Lee JM, Hong SH, Kim GH, Lee JY, Han JK, Choi BI. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy. Radiology. 2009;253(1):116–25.

    Article  PubMed  Google Scholar 

  88. Quick HH, von Gall C, Zeilinger M, Wiesmüller M, Braun H, Ziegler S, Kuwert T, Uder M, Dörfler A, Kalender WA, Lell M. Integrated whole-body PET/MR hybrid imaging: clinical experience. Invest Radiol. 2013;48(5):280–9.

    Article  PubMed  Google Scholar 

  89. Makino K, Hirai T, Nakamura H, Murakami R, Kitajima M, Shigematsu Y, Nakashima R, Shiraishi S, Uetani H, Iwashita K, Akter M, Yamashita Y, Kuratsu J. Does adding FDG-PET to MRI improve the differentiation between primary cerebral lymphoma and glioblastoma? Observer performance study. Ann Nucl Med. 2011;25(6):432–8.

    Article  PubMed  Google Scholar 

  90. Ewelt C, Floeth FW, Felsberg J, Steiger HJ, Sabel M, Langen KJ, Stoffels G, Stummer W. Finding the anaplastic focus in diffuse gliomas: the value of Gd-DTPA enhanced MRI, FET-PET, and intraoperative, ALA-derived tissue fluorescence. Clin Neurol Neurosurg. 2011;113(7):541–7.

    Article  PubMed  Google Scholar 

  91. Alonzi R, Padhani AR, Allen C. Dynamic contrast enhanced MRI in prostate cancer. Eur J Radiol. 2007;63(3):335–50.

    Article  PubMed  Google Scholar 

  92. Chen K, Cai W, Li ZB, Wang H, Chen X. Quantitative PET imaging of VEGF receptor expression. Mol Imaging Biol. 2009;11(1):15–22.

    Article  PubMed  Google Scholar 

  93. Gore JC, Manning HC, Quarles CC, Waddell KW, Yankeelov TE. Magnetic resonance in the era of molecular imaging of cancer. Magn Reson Imaging. 2011;29(5):587–600.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, University Hospitals Case Medical Center, Cleveland, OH, USA

    Sasan Partovi, Andres Kohan, Raj Mohan Paspulati MD, Pablo R. Ros & Karin A. Herrmann

Authors
  1. Sasan Partovi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andres Kohan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Raj Mohan Paspulati MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pablo R. Ros
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Karin A. Herrmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karin A. Herrmann .

Editor information

Editors and Affiliations

  1. Depto. Medicina Nuclear, Autonomous University of Barcelona Hospital Sant Pau, Barcelona, Spain

    Ignasi Carrio

  2. Department of Radiology, University Hospitals Case Medical Center, Cleveland, Ohio, USA

    Pablo Ros

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Partovi, S., Kohan, A., Paspulati, R.M., Ros, P.R., Herrmann, K.A. (2014). PET/MR in Colorectal Cancer. In: Carrio, I., Ros, P. (eds) PET/MRI. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-40692-8_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-40692-8_7

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-40691-1

  • Online ISBN: 978-3-642-40692-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation